Sadar Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 7 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 1035.64%
(FY 2023)
- Profit 1270.96%
(FY 2023)
- Ebitda 2666.58%
(FY 2023)
- Net Worth 406.10%
(FY 2023)
- Total Assets 1168.57%
(FY 2023)
About Sadar Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammad Ahmed and Sarfaraz Alam serve as directors at the Company.
- CIN/LLPIN
U51909GA2017PTC013427
- Company No.
013427
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Calangute, Goa, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sadar Biotech Private Limited offer?
Sadar Biotech Private Limited offers a wide range of products and services, including Computer & Mobile Apps Development, Application Development Service.
Who are the key members and board of directors at Sadar Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammad Ahmed  | Director | 12-Dec-2017 | Current |
| Sarfaraz Alam | Director | 12-Dec-2017 | Current |
Financial Performance of Sadar Biotech.
Sadar Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1035.64% increase. The company also saw a substantial improvement in profitability, with a 1270.96% increase in profit. The company's net worth Soared by an impressive increase of 406.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sadar Biotech?
In 2022, Sadar Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Roosters Guest House Private LimitedActive 19 years 10 monthsMohammad Ahmed and Sarfaraz Alam are mutual person
- Pirache Cordiality Private LimitedActive 10 years 9 months
Mohammad Ahmed and Sarfaraz Alam are mutual person
- Kartina Entertainment And Sports Private LimitedActive 5 years 8 months
Mohammad Ahmed and Sarfaraz Alam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sadar Biotech?
Unlock and access historical data on people associated with Sadar Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sadar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sadar Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
